Chat with GenHealth to automate any coding or chart task.
Name of the Condition
- Diabetes mellitus due to underlying condition with proliferative diabetic retinopathy with traction retinal detachment involving the macula, left eye
Summary
This condition involves diabetes mellitus resulting from an underlying health issue, accompanied by proliferative diabetic retinopathy and traction retinal detachment involving the macula of the left eye. Proliferative diabetic retinopathy is an advanced stage of retinal damage caused by prolonged high blood sugar, characterized by the growth of abnormal blood vessels on the retina. Traction retinal detachment occurs when these abnormal vessels and scar tissue pull the retina away from its normal position, and when the macula is involved, it can lead to severe vision loss if not addressed.
Causes
The condition arises when an underlying disease impairs insulin production or function, leading to secondary diabetes. Examples of such underlying conditions include pancreatic disorders, hormonal imbalances, or genetic syndromes. Persistent hyperglycemia from this secondary diabetes damages retinal blood vessels, triggering proliferative changes. The abnormal blood vessel growth and associated scar tissue then exert traction on the retina, causing detachment, particularly when the macula is affected.
Risk Factors
- Having a medical condition known to cause secondary diabetes.
- Long-standing uncontrolled blood sugar levels.
- High blood pressure and elevated cholesterol.
- Smoking and obesity.
- Advanced age.
Symptoms
- Blurred or distorted vision in the left eye.
- Floaters or dark spots in the visual field of the left eye.
- Difficulty seeing colors in the left eye.
- Poor night vision in the left eye.
- Vision loss, potentially severe if untreated.
Diagnosis
Diagnosis requires a comprehensive dilated eye exam to assess retinal health, with specific attention to the left eye. Additional tests, such as optical coherence tomography (OCT) or fluorescein angiography, may be used to confirm traction retinal detachment and proliferative changes. Blood tests to evaluate glycemic control and identify underlying conditions contributing to secondary diabetes are also typically performed.
Treatment Options
Treatment focuses on managing blood sugar levels to slow retinal damage and addressing the retinal detachment. Options may include laser photocoagulation to reduce abnormal blood vessel growth, vitrectomy surgery to remove scar tissue and reattach the retina, and anti-VEGF injections to inhibit vessel proliferation. Underlying conditions causing secondary diabetes must also be managed to improve overall glycemic control.
Prognosis and Follow-Up
Prognosis depends on the severity of retinal detachment and the effectiveness of treatment. Early intervention can preserve vision, but advanced detachment may result in permanent vision loss. Regular follow-up with an ophthalmologist is essential to monitor retinal health and adjust treatment as needed. Glycemic control and management of underlying conditions are critical for long-term outcomes.
Complications
- Permanent vision loss in the left eye.
- Recurrent retinal detachment.
- Progression to blindness if untreated.
- Increased risk of other diabetic eye complications, such as macular edema.
Lifestyle & Prevention
- Maintain strict blood sugar control through diet, exercise, and medication.
- Manage blood pressure and cholesterol levels.
- Avoid smoking and limit alcohol consumption.
- Attend regular eye exams to detect retinal changes early.
- Treat underlying conditions promptly to reduce secondary diabetes risk.
When to Seek Professional Help
Seek immediate medical attention if you experience sudden vision changes, such as blurred vision, floaters, or vision loss in the left eye. Prompt evaluation is crucial to prevent permanent damage from traction retinal detachment.
Tips for Medical Coders
Document the specific eye (left eye) and the presence of traction retinal detachment involving the macula. Ensure the underlying condition causing diabetes is clearly specified, as this differentiates secondary diabetes from primary types. Verify that proliferative diabetic retinopathy is documented, as it is a key component of the code.
E08.3522 policy automation walkthrough
Walk through the policies, prior authorization requirements, and workflow automation opportunities connected to this code.